Cita APA (7a ed.)
Langeberg, W. J., Siozon, C. C., Page, J. H., Morrow, P. K., & Chia, V. M. (2014). Use of pegfilgrastim primary prophylaxis and risk of infection, by chemotherapy cycle and regimen, among patients with breast cancer or non-Hodgkin’s lymphoma. Supportive Care in Cancer, 22(8), 2167-2176.
Cita Chicago Style (17a ed.)
Langeberg, Wendy J., Conchitina C. Siozon, John H. Page, P. K. Morrow, y Victoria M. Chia. "Use of Pegfilgrastim Primary Prophylaxis and Risk of Infection, by Chemotherapy Cycle and Regimen, Among Patients with Breast Cancer or Non-Hodgkin’s Lymphoma." Supportive Care in Cancer 22, no. 8 (2014): 2167-2176.
Cita MLA (9a ed.)
Langeberg, Wendy J., et al. "Use of Pegfilgrastim Primary Prophylaxis and Risk of Infection, by Chemotherapy Cycle and Regimen, Among Patients with Breast Cancer or Non-Hodgkin’s Lymphoma." Supportive Care in Cancer, vol. 22, no. 8, 2014, pp. 2167-2176.
Precaución: Estas citas no son 100% exactas.